Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am Heart J
3 Am J Hypertens
1 Am J Med
1 Circ Cardiovasc Qual Outcomes
1 Clin Cardiol
4 Clin Exp Hypertens
1 Curr Opin Nephrol Hypertens
1 Diabet Med
2 Diabetes Care
1 Dtsch Med Wochenschr
2 Eur Heart J
2 Hypertension
3 J Am Coll Cardiol
1 J Am Soc Nephrol
1 J Cardiovasc Pharmacol
2 J Hum Hypertens
35 J Hypertens
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. ZHEUTLIN AR, Derington CG, King JB, Berchie RO, et al
    Factors Associated with Antihypertensive Monotherapy Among US Adults with Treated Hypertension and Uncontrolled Blood Pressure Overall and by Race/Ethnicity, NHANES 2013-2018.
    Am Heart J. 2021 Oct 15. pii: S0002-8703(21)00436.
    PubMed         Abstract available

    Am J Hypertens

  2. WANG D, Xu JZ, Kang YY, Zhang W, et al
    Aortic root diameter in hypertensive patients with various stages of obstructive sleep apnea.
    Am J Hypertens. 2021 Oct 18. pii: 6400015. doi: 10.1093.
    PubMed         Abstract available

  3. TAJEU GS, Tsipas S, Rakotz M, Wozniak G, et al
    Cost-Effectiveness of Recommendations from the Surgeon General's Call-to-Action to Control Hypertension.
    Am J Hypertens. 2021 Oct 18. pii: 6400065. doi: 10.1093.
    PubMed         Abstract available

  4. NICOLI CD, Long DL, Plante TB, Howard G, et al
    Pro-Neurotensin/Neuromedin N and Hypertension Risk: a Prospective Study.
    Am J Hypertens. 2021 Oct 16. pii: 6398602. doi: 10.1093.
    PubMed         Abstract available

    Am J Med

  5. LU Y, Krumholz HM
    Persistent Hypertension: A Broader Framework for Improving Blood Pressure Control.
    Am J Med. 2021 Oct 14. pii: S0002-9343(21)00652.

    Circ Cardiovasc Qual Outcomes

  6. LUONG P, Glorioso TJ, Grunwald GK, Peterson P, et al
    Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study.
    Circ Cardiovasc Qual Outcomes. 2021;14:e007015.
    PubMed         Abstract available

    Clin Cardiol

  7. BORTNICK AE, Shahid M, Shitole SG, Park M, et al
    Outcomes of ST-elevation myocardial infarction by age and sex in a low-income urban community: The Montefiore STEMI Registry.
    Clin Cardiol. 2020;43:1100-1109.
    PubMed         Abstract available

    Clin Exp Hypertens

  8. PERGEL A, Demiral G, Tumkaya L, Mercantepe T, et al
    The protective effects of topiramate on intestinal injury induced with infrarenal aortic occlusion via oxidative stress and apoptosis.
    Clin Exp Hypertens. 2021;43:604-609.
    PubMed         Abstract available

  9. BAGCI A, Aksoy F, Bas HA, Isik IB, et al
    The effect of Systolic and diastolic blood pressure on Tp-e interval in patients divided according to World Health Organization classification for body mass index.
    Clin Exp Hypertens. 2021;43:642-646.
    PubMed         Abstract available

  10. KARTAL S, Sen A, Tumkaya L, Erdivanli B, et al
    The effect of dexmedetomidine on liver injury secondary to lower extremity ischemia-reperfusion in a diabetic rat model.
    Clin Exp Hypertens. 2021;43:677-682.
    PubMed         Abstract available

  11. CONER A, Akbay E, Akinci S, Ozyildiz G, et al
    Determinants of reverse dipping blood pressure in normotensive, non-diabetic population with an office measurement below 130/85mmHg.
    Clin Exp Hypertens. 2021;43:647-652.
    PubMed         Abstract available

    Curr Opin Nephrol Hypertens

  12. KOURI AM, Rheault MN
    Cardiovascular disease in children with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99002.
    PubMed         Abstract available

    Diabet Med

  13. VESTGAARD M, Al-Saudi E, Asbjornsdottir B, Norgaard LN, et al
    The impact of anti-hypertensive treatment on fetal growth and haemodynamics in pregnant women with pre-existing diabetes - an explorative study.
    Diabet Med. 2021 Oct 15:e14722. doi: 10.1111/dme.14722.
    PubMed         Abstract available

    Diabetes Care

  14. ALFEGO D, Ennis J, Gillespie B, Lewis MJ, et al
    Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database.
    Diabetes Care. 2021;44:2025-2032.
    PubMed         Abstract available

  15. YAMADA MH, Fujihara K, Kodama S, Sato T, et al
    Associations of Systolic Blood Pressure and Diastolic Blood Pressure With the Incidence of Coronary Artery Disease or Cerebrovascular Disease According to Glucose Status.
    Diabetes Care. 2021;44:2124-2131.
    PubMed         Abstract available

    Dtsch Med Wochenschr

  16. HELD M, Weiner S, Walthelm J, Joa F, et al
    [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
    Dtsch Med Wochenschr. 2021 Oct 20:e88-e94. doi: 10.1055/a-1555-0345.
    PubMed         Abstract available

    Eur Heart J

  17. MIHAILIDOU AS, Gulati M
    Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION.
    Eur Heart J. 2021 Oct 18. pii: 6399973. doi: 10.1093.

  18. LINZ D, Gawalko M, Sanders P, Penders J, et al
    Does gut microbiota affect atrial rhythm? Causalities and speculations.
    Eur Heart J. 2021;42:3521-3525.
    PubMed         Abstract available


  19. CHEN HH, Wan SH, Iyer SR, Cannone V, et al
    First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension.
    Hypertension. 2021 Oct 18:HYPERTENSIONAHA12117159.
    PubMed         Abstract available

  20. HUNDEMER GL, Imsirovic H, Vaidya A, Yozamp N, et al
    Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study.
    Hypertension. 2021 Oct 18:HYPERTENSIONAHA12118118.
    PubMed         Abstract available

    J Am Coll Cardiol

  21. BRESS AP, Greene T, Derington CG, Shen J, et al
    Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
    J Am Coll Cardiol. 2021;77:1977-1990.
    PubMed         Abstract available

  22. DIAMOND JA, Schussheim AE, Phillips RA
    Another Nudge to Overcome the Treatment-Risk Paradox in Blood Pressure Management.
    J Am Coll Cardiol. 2021;77:1991-1993.

  23. JAFAR TH, Kyobutungi C
    A Good Start to Lowering BP and CVD Risk in Sub-Saharan Africa.
    J Am Coll Cardiol. 2021;77:2019-2021.

    J Am Soc Nephrol

  24. ROBINSON C, Jeyakumar N, Luo B, Wald R, et al
    Long-term Kidney Outcomes Following Childhood Acute Kidney Injury Receiving Dialysis: A Population-based Cohort Study.
    J Am Soc Nephrol. 2021 May 26. pii: ASN.2020111665. doi: 10.1681/ASN.2020111665.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  25. ADIE SK, Abdul-Aziz AA, Ketcham SW, Moles VM, et al
    Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98139.
    PubMed         Abstract available

    J Hum Hypertens

  26. SERYAN A, Martin M, Hamimatunnisa J, Annette P, et al
    Cardiovascular mortality risk in young adults with isolated systolic hypertension: findings from population-based MONICA/KORA cohort study.
    J Hum Hypertens. 2021 Oct 14. pii: 10.1038/s41371-021-00619.
    PubMed         Abstract available

  27. DUTTA A, Nayak G
    Concerns about the prevalence estimates of undiagnosed hypertension among women aged 15-49 years in India.
    J Hum Hypertens. 2021 Oct 14. pii: 10.1038/s41371-021-00626.

    J Hypertens

  28. HEFFERNAN KS, Jae SY, Loprinzi PD
    Estimated pulse wave velocity is associated with residual-specific mortality: findings from the National Health and Nutrition Examination Survey.
    J Hypertens. 2021;39:698-702.
    PubMed         Abstract available

  29. ALSHAARAWY O, Vanderziel A
    Visit-to-visit variability in blood pressure among cannabis users participating in the Third National Health and Nutrition Examination Survey.
    J Hypertens. 2021;39:621-626.
    PubMed         Abstract available

  30. MALOBERTI A, Bombelli M, Facchetti R, Barbagallo CM, et al
    Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study.
    J Hypertens. 2021;39:333-340.
    PubMed         Abstract available

  31. NEWTON J, Singh C, Sinha MD
    Measurement of SBP at home by parents using hand-held Doppler device and aneroid sphygmomanometer: a single-centre experience.
    J Hypertens. 2021;39:904-910.
    PubMed         Abstract available

  32. GIBBS J, Gaskin E, Ji C, Miller MA, et al
    The effect of plant-based dietary patterns on blood pressure: a systematic review and meta-analysis of controlled intervention trials.
    J Hypertens. 2021;39:23-37.
    PubMed         Abstract available

  33. ESLER MD, Jennings G, Schlaich M, Lambert G, et al
    The adrenal medulla in cardiovascular medicine: an untold story.
    J Hypertens. 2021;39:819-829.
    PubMed         Abstract available

  34. LUCHI WM, Crajoinas RO, Martins FL, Castro PC, et al
    High blood pressure induced by vitamin D deficiency is associated with renal overexpression and hyperphosphorylation of Na+-K+-2Cl- cotransporter type 2.
    J Hypertens. 2021;39:880-891.
    PubMed         Abstract available

  35. COWELL OR, Mistry N, Deighton K, Matu J, et al
    Effects of a Mediterranean diet on blood pressure: a systematic review and meta-analysis of randomized controlled trials and observational studies.
    J Hypertens. 2021;39:729-739.
    PubMed         Abstract available

  36. CUSPIDI C, Tadic M, Sala C, Quarti-Trevano F, et al
    Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
    J Hypertens. 2021;39:775-783.
    PubMed         Abstract available

  37. TODKAR S, Padwal R, Michaud A, Cloutier L, et al
    Knowledge, perception and practice of health professionals regarding blood pressure measurement methods: a scoping review.
    J Hypertens. 2021;39:391-399.
    PubMed         Abstract available

  38. EDWARDS JJ, Taylor KA, Cottam C, Jalaludeen N, et al
    Ambulatory blood pressure adaptations to high-intensity interval training: a randomized controlled study.
    J Hypertens. 2021;39:341-348.
    PubMed         Abstract available

  39. MATSUMOTO K, Jin Z, Homma S, Elkind MSV, et al
    Office, central and ambulatory blood pressure for predicting incident atrial fibrillation in older adults.
    J Hypertens. 2021;39:46-52.
    PubMed         Abstract available

  40. CAI P, Peng Y, Chen Y, Wang Y, et al
    Blood pressure characteristics of subclinical hypothyroidism: an observation study combined with office blood pressure and 24-h ambulatory blood pressure.
    J Hypertens. 2021;39:453-460.
    PubMed         Abstract available

  41. SALVETTI M, Paini A, Bertacchini F, Aggiusti C, et al
    Myocardial mechano-energetic efficiency in primary aldosteronism.
    J Hypertens. 2021;39:318-324.
    PubMed         Abstract available

  42. CUSPIDI C, Tadic M, Sala C, Quarti-Trevano F, et al
    Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis.
    J Hypertens. 2021;39:4-11.
    PubMed         Abstract available

  43. MUIESAN ML, Salvetti M, Virdis A, Masi S, et al
    Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study.
    J Hypertens. 2021;39:62-69.
    PubMed         Abstract available

  44. KIM W, Kim SH, Choi CU, Lee SK, et al
    Role of arterial stiffness in the association between hand grip strength and cardiovascular events: the Korean Genome and Epidemiology Study.
    J Hypertens. 2021;39:1203-1209.
    PubMed         Abstract available

  45. CREMER A, Doublet J, Boulestreau R, Gaudissard J, et al
    Short-term blood pressure variability, arterial stiffness, and cardiovascular events: results from the Bordeaux cohort.
    J Hypertens. 2021;39:947-951.
    PubMed         Abstract available

  46. THOMOPOULOS C, Bazoukis G, Grassi G, Tsioufis C, et al
    Monotherapy vs combination treatments of different complexity: a meta-analysis of blood pressure lowering randomized outcome trials.
    J Hypertens. 2021;39:846-855.
    PubMed         Abstract available

  47. SISO-ALMIRALL A, Kostov B, Blat E, Garcia N, et al
    Validity and reliability of 1-h automated office blood pressure measurement for the diagnosis of hypertension.
    J Hypertens. 2021 Oct 13. pii: 00004872-900000000-96551.
    PubMed         Abstract available

  48. HISAMATSU T, Lloyd-Jones DM, Colangelo LA, Liu K, et al
    Urinary sodium and potassium excretions in young adulthood and blood pressure by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    J Hypertens. 2021;39:1586-1593.
    PubMed         Abstract available

  49. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
    Effectiveness of statin intensive therapy in type 2 diabetes mellitus with high visit-to-visit blood pressure variability.
    J Hypertens. 2021 May 17. pii: 00004872-900000000-96668.
    PubMed         Abstract available

  50. FAN WG, Wang WY, Meng YX, Sharman JE, et al
    Within-visit and between-visit intra-individual blood pressure variability in an unselected adult population from rural China.
    J Hypertens. 2021;39:1346-1351.
    PubMed         Abstract available

  51. Association of age and blood pressure among 3.3 million adults: insights from China PEACE million persons project.
    J Hypertens. 2021;39:1143-1154.
    PubMed         Abstract available

  52. ROSELEUR J, Gonzalez-Chica DA, Bernardo CO, Geisler BP, et al
    Blood pressure control in Australian general practice: analysis using general practice records of 1.2 million patients from the MedicineInsight database.
    J Hypertens. 2021;39:1134-1142.
    PubMed         Abstract available

  53. WANG N, Harris K, Chalmers J, Harrap S, et al
    Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials.
    J Hypertens. 2021;39:1689-1696.
    PubMed         Abstract available

  54. YANNOUTSOS A, Lin F, Billuart O, Buronfosse A, et al
    Low admission blood pressure as a marker of poor 1-year survival in patients with revascularized critical limb ischemia.
    J Hypertens. 2021;39:1611-1620.
    PubMed         Abstract available

  55. TOSELLO F, Guala A, D'ascenzo F, Bollati M, et al
    Central pulse pressure is inversely associated with proximal aortic remodelling.
    J Hypertens. 2021;39:919-925.
    PubMed         Abstract available

  56. SEIDEL M, Pagonas N, Seibert FS, Bauer F, et al
    The differential impact of aerobic and isometric handgrip exercise on blood pressure variability and central aortic blood pressure.
    J Hypertens. 2021;39:1269-1273.
    PubMed         Abstract available

  57. NOLDE JM, Lugo-Gavidia LM, Kannenkeril D, Chan J, et al
    Increased pulse wave velocity in patients with an orthostatic blood pressure rise independent of other cardiovascular risk factors.
    J Hypertens. 2021;39:1352-1360.
    PubMed         Abstract available

  58. ROUSH GC, Messerli FH
    Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects.
    J Hypertens. 2021;39:1254-1260.
    PubMed         Abstract available

  59. MARCINIAK M, Gilbert A, Loncaric F, Fernandes JF, et al
    Septal curvature as a robust and reproducible marker for basal septal hypertrophy.
    J Hypertens. 2021;39:1421-1428.
    PubMed         Abstract available

  60. BOHM M, Schumacher H, Teo KK, Lonn EM, et al
    Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
    J Hypertens. 2021 Feb 3. pii: 00004872-900000000-96717.
    PubMed         Abstract available

  61. CLARKE MM, Harrington HA, Glenning JP, Zannino D, et al
    Magnitude and significance of interarm blood pressure differences in children and adolescents.
    J Hypertens. 2021;39:1341-1345.
    PubMed         Abstract available

  62. CUSPIDI C, Tadic M, Sala C, Carugo S, et al
    Reverse dipping and subclinical cardiac organ damage: a meta-analysis of echocardiographic studies.
    J Hypertens. 2021;39:1505-1512.
    PubMed         Abstract available

    PLoS One

  63. CHRISTIAN AK, Sanuade OA, Kushitor SB, Kushitor M, et al
    Metabolic syndrome among individuals living with hypertension in Accra, Ghana.
    PLoS One. 2021;16:e0253837.
    PubMed         Abstract available

  64. LUKAS K, Markos E, Belayneh F, Habte A, et al
    The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020: A hospital-based cross-sectional study.
    PLoS One. 2021;16:e0258576.
    PubMed         Abstract available

  65. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed         Abstract available

  66. KIM GR, Zhao T, Kee HJ, Kee SJ, et al
    MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA.
    PLoS One. 2021;16:e0249146.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.